The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases

被引：0
|
作者：
Rui Kitadai
Yusuke Okuma
Taiki Hakozaki
Yukio Hosomi
机构：
[1] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Thoracic Oncology and Respiratory Medicine
[2] National Cancer Center Hospital,Department of Thoracic Oncology
来源：
Journal of Cancer Research and Clinical Oncology | 2020年 / 146卷
关键词：
Non-small-cell lung cancer; Liver metastasis; Nivolumab; Pembrolizumab; Atezolizumab; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：777 / 785
页数：8
相关论文
共 50 条
  • [1] The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases
    Kitadai, Rui
    Okuma, Yusuke
    Hakozaki, Taiki
    Hosomi, Yukio
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 777 - 785
  • [2] Immune Checkpoint Inhibitors for Brain Metastases of Non-Small-Cell Lung Cancer
    Ashinuma, H.
    Shingyoji, M.
    Iuchi, T.
    Yoshida, Y.
    Setoguchi, T.
    Hasegawa, Y.
    Sakaida, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2420 - S2420
  • [3] Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?
    Mok, Tony S. K.
    Loong, Herbert H.
    [J]. LANCET, 2016, 387 (10027): : 1488 - 1490
  • [4] Combing Immune Checkpoint Inhibitors with Radiotherapy in Advanced Non-small-cell Lung Cancer
    Zou, Y.
    Chen, Y.
    Zhou, X.
    Gong, Y.
    Xu, Y.
    Zou, B.
    Peng, F.
    Huang, M.
    Lu, Y.
    Liu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S625 - S625
  • [5] Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients
    Gobbini, Elisa
    Toffart, Anne Claire
    Perol, Maurice
    Assie, Jean-Baptiste
    Duruisseaux, Michael
    Coupez, Dahna
    Dubos, Catherine
    Westeel, Virginie
    Delaunay, Myriam
    Guisier, Florian
    Veillon, Remi
    Gounant, Valerie
    Leprieur, Etienne Giroux
    Vanel, Francois-Roger
    Chaabane, Nouha
    Dansin, Eric
    Babey, Helene
    Decroisette, Chantal
    Barlesi, Fabrice
    Daniel, Catherine
    Fournel, Pierre
    Mezquita, Laura
    Oulkhouir, Youssef
    Canellas, Anthony
    Duchemann, Boris
    Molinier, Olivier
    Alcazer, Vincent
    Moro-Sibilot, Denis
    Levra, Matteo Giaj
    [J]. CLINICAL LUNG CANCER, 2020, 21 (05) : E497 - E510
  • [6] Biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer
    Fuschillo, Salvatore
    Battiloro, Ciro
    Rocco, Danilo
    D Gravara, Luigi
    Motta, Andrea
    Maniscalco, Mauro
    [J]. BIOMARKERS IN MEDICINE, 2020, 14 (11) : 929 - 932
  • [7] Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases
    Qiao, Meng
    Zhou, Fei
    Hou, Likun
    Li, Xuefei
    Zhao, Chao
    Jiang, Tao
    Gao, Guanghui
    Su, Chunxia
    Wu, Chunyan
    Ren, Shengxiang
    Zhou, Caicun
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (01)
  • [8] Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review
    Ellis, Peter M.
    Vella, Emily T.
    Ung, Yee C.
    [J]. CLINICAL LUNG CANCER, 2017, 18 (05) : 444 - U75
  • [9] Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain Metastases
    Porte, Judith
    Saint-Martin, Caroline
    Frederic-Moreau, Thomas
    Massiani, Marie-Ange
    Bozec, Laurence
    Cao, Kim
    Verrelle, Pierre
    Otz, Joelle
    Jadaud, Eric
    Minsat, Mathieu
    Langer, Adriana
    Girard, Nicolas
    Crehange, Gilles
    Beddok, Arnaud
    [J]. BIOMEDICINES, 2022, 10 (09)
  • [10] Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with liver metastases
    Fan-jie Qu
    Yi Zhou
    Shuang Wu
    [J]. British Journal of Cancer, 2024, 130 : 165 - 175
12345